ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Neurology

Top Neurology Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ROBERT KRONENBERG M.D.

Neurology

547

$57.8K

20
0 are 65+

85%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 27%

$106
Average prescription price

Avg: $204

ADAM FALCHOOK MD

Neurology

152

$18.6K

28
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$122
Average prescription price

Avg: $204

DAVID BURKS MD

Neurology

209

$20.8K

34
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$99
Average prescription price

Avg: $204

KEVIN BOYLAN MD

Neurology

189

$85.9K

35
22 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 27%

$455
Average prescription price

Avg: $204

RICHARD ISAACSON M.D.

Neurology

362

$52.9K

36
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

48%
prescriptions for brand name drugs

Avg: 27%

$146
Average prescription price

Avg: $204

HAROLD FRIEND MD

Neurology

545

$66.1K

37
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

32%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 27%

$121
Average prescription price

Avg: $204

ZBIGNIEW WSZOLEK M.D.

Neurology

298

$79.6K

40
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

41%
prescriptions for brand name drugs

Avg: 27%

$267
Average prescription price

Avg: $204

DAVID SHAW MD

Neurology

242

$26.8K

42
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 27%

$111
Average prescription price

Avg: $204

EVAN GEDZELMAN M.D.

Neurology

344

$111K

42
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 27%

$322
Average prescription price

Avg: $204

NILUFER TANER M.D., PHD

Neurology

212

$38.5K

43
38 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

49%
prescriptions for brand name drugs

Avg: 27%

$182
Average prescription price

Avg: $204

HOLLY SKINNER DO

Neurology

326

$38.7K

44
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 27%

$119
Average prescription price

Avg: $204

WILLIAM TRIGGS MD

Neurology

371

$80.6K

45
25 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 27%

$217
Average prescription price

Avg: $204

TARIQ IRFAN MD

Neurology

299

$82.7K

45
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 27%

$277
Average prescription price

Avg: $204

JERRY SHIH M.D.

Neurology

362

$123K

46
25 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

41%
prescriptions for brand name drugs

Avg: 27%

$339
Average prescription price

Avg: $204

ABBAS KHORASANEE MD

Neurology

175

$9,443

47
0 are 65+

85%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 27%

$54
Average prescription price

Avg: $204

AMOS GIPSON MD

Neurology

250

$20.5K

48
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

14%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 27%

$82
Average prescription price

Avg: $204

JOSEPH DUROZEL MD

Neurology

287

$13.3K

53
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 27%

$46
Average prescription price

Avg: $204

RODRIGO KULJIS

Neurology

409

$70.4K

54
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

47%
prescriptions for brand name drugs

Avg: 27%

$172
Average prescription price

Avg: $204

STEPHEN NADEAU MD

Neurology

1,441

$151K

55
18 are 65+

58%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

14%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$105
Average prescription price

Avg: $204

SILVIA DELGADO

Neurology

704

$893K

56
17 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

40%
prescriptions for brand name drugs

Avg: 27%

$1269
Average prescription price

Avg: $204

MARK WERNER MD

Neurology

522

$88.4K

56
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$169
Average prescription price

Avg: $204

ELIZABETH SHUSTER M.D.

Neurology

404

$808K

56
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

56%
prescriptions for brand name drugs

Avg: 27%

$2001
Average prescription price

Avg: $204

JUDY WHITE M.D.

Neurology

450

$110K

56
38 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 27%

$246
Average prescription price

Avg: $204

JOSEPHINE LIM MD

Neurology

393

$28.5K

57
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 27%

$73
Average prescription price

Avg: $204

SAJEEL CHOWDHARY MD

Neurology

448

$29.1K

59
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

10%
prescriptions for brand name drugs

Avg: 27%

$65
Average prescription price

Avg: $204

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank